116 related articles for article (PubMed ID: 27342501)
1. [Clinical Analysis of Autologous Cytokine-induced Killer Cells Combined with IL-2 for Treating of Elderly Patients with B-cell Malignant Lymphoma].
Wu Y; Shi L; Feng L; Lv DL
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2016 Jun; 24(3):738-43. PubMed ID: 27342501
[TBL] [Abstract][Full Text] [Related]
2. [Clinical study of autologous cytokine induced killer cells combined with IL-2 for therapy of elderly patients with B-cell malignant lymphoma].
Yang B; Lu XC; Zhu HL; Han WD; Wang Y; Fan H; Li SX; Liu Y; Dai HR; Yao SQ
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2010 Oct; 18(5):1244-9. PubMed ID: 21129269
[TBL] [Abstract][Full Text] [Related]
3. Clinical study of autologous cytokine-induced killer cells for the treatment of elderly patients with diffuse large B-cell lymphoma.
Lu XC; Yang B; Yu RL; Chi XH; Tuo S; Tuo CW; Zhu HL; Wang Y; Jiang CG; Fu XB; Yang Y; Liu Y; Yao SQ; Dai HR; Cai L; Li BJ; Han WD
Cell Biochem Biophys; 2012 Jan; 62(1):257-65. PubMed ID: 21913005
[TBL] [Abstract][Full Text] [Related]
4. Repeated transfusions of autologous cytokine-induced killer cells for treatment of haematological malignancies in elderly patients: a pilot clinical trial.
Yang B; Lu XC; Yu RL; Chi XH; Liu Y; Wang Y; Dai HR; Zhu HL; Cai LL; Han WD
Hematol Oncol; 2012 Sep; 30(3):115-22. PubMed ID: 22972689
[TBL] [Abstract][Full Text] [Related]
5. [Curative efficiency of rituximab combined with autologous cytokine induced killer cells on aged patient with orbital diffuse large B cell lymphoma].
Li SX; Zhu HL; Guo B; Lu XC; Fan H; Lin J; Yang B; Liu Y; Yang Y; Ran HH; Zhai B; Han WD; Wang Y; Yao SQ
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2012 Oct; 20(5):1117-21. PubMed ID: 23114130
[TBL] [Abstract][Full Text] [Related]
6. [Short-term curative efficacy of autologous cytokine induced killer cells combined with low-dose IL-2 regimen containing immune enhancement by thymic peptide in elderly patients with B-cell chronic lymphocytic leukemia].
Cai LL; Yang Y; Yang B; Zhu HL; Lu XC; Zhang WY; Yu RL; Chi XH; Wang Y; Dai HR; Han WD; Fan H; Li SX; Liu Y; Ran HH; Lin J; Tuo S; Tuo CW; Zhang F; Cao JP; Yao SQ
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2012 Jun; 20(3):564-70. PubMed ID: 22739156
[TBL] [Abstract][Full Text] [Related]
7. [Application of immune function test to evaluate effect of cytokine-induced autologous killer cell infusion for elderly patients with hematological malignancies].
Cai LL; Yang B; Lu XC; Zhu HL; Han WD; Wang Y; Liu Y; Dai HR; Yao SQ
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2010 Oct; 18(5):1250-5. PubMed ID: 21129270
[TBL] [Abstract][Full Text] [Related]
8. Cytokine-induced killer cells in the treatment of patients with solid carcinomas: a systematic review and pooled analysis.
Ma Y; Zhang Z; Tang L; Xu YC; Xie ZM; Gu XF; Wang HX
Cytotherapy; 2012 Apr; 14(4):483-93. PubMed ID: 22277010
[TBL] [Abstract][Full Text] [Related]
9. Cytokine-induced killer cells/dendritic cells-cytokine induced killer cells immunotherapy combined with chemotherapy for treatment of colorectal cancer in China: a meta-analysis of 29 trials involving 2,610 patients.
Zhang L; Mu Y; Zhang A; Xie J; Chen S; Xu F; Wang W; Zhang Y; Ren S; Zhou C
Oncotarget; 2017 Jul; 8(28):45164-45177. PubMed ID: 28404886
[TBL] [Abstract][Full Text] [Related]
10. Autologous cytokine-induced killer (CIK) cell immunotherapy combined with cyclophosphamide in five patients with POEMS syndrome.
Ma L; Wang Y; Bo J; Han W; Wang Y; Zhang L; Wu X; Yu S; Liu R
Clin Exp Immunol; 2016 Apr; 184(1):83-9. PubMed ID: 26660736
[TBL] [Abstract][Full Text] [Related]
11. [Preliminary assessment of immune reconstitution after autologous peripheral hematopoietic stem cell transplantation (AHSCT)].
Huang HQ; Cai QC; Shi YX; Lin XB; Wei J; Guo Y; Pan ZH
Ai Zheng; 2006 Aug; 25(8):1023-8. PubMed ID: 16965687
[TBL] [Abstract][Full Text] [Related]
12. Effectiveness and safety of chemotherapy combined with cytokine-induced killer cell /dendritic cell-cytokine-induced killer cell therapy for treatment of gastric cancer in China: A systematic review and meta-analysis.
Mu Y; Zhou CH; Chen SF; Ding J; Zhang YX; Yang YP; Wang WH
Cytotherapy; 2016 Sep; 18(9):1162-77. PubMed ID: 27421742
[TBL] [Abstract][Full Text] [Related]
13. Autologous cytokine-induced killer cell therapy in lung cancer patients: a retrospective study.
Zhang J; Zhu L; Du H; He X; Yin Y; Gu Y; Liu L; Lu K; Guo R; Liu P; Shu Y
Biomed Pharmacother; 2015 Mar; 70():248-52. PubMed ID: 25776508
[TBL] [Abstract][Full Text] [Related]
14. [Comparison of Several Optimization Schemes for the Induction and Expansion of Antibody-Mediated High Efficiency CIK (AMHE-CIK) In Vitro].
Yin X; Xu X; Zhao Y; Wang ZJ; Wang HY; Hu ZB
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2016 Feb; 24(1):191-6. PubMed ID: 26913419
[TBL] [Abstract][Full Text] [Related]
15. [Autologous CIK cell infusion promotes amplification ability of CD3⁺ CD56⁺ cells when re-preparation from patients with malignant tumors].
Yu H; Sun Y; Lin D; Li C; Chen W; Ma D
Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi; 2014 Jul; 30(7):748-53, 758. PubMed ID: 25001943
[TBL] [Abstract][Full Text] [Related]
16. Optimized protocols for generation of cord blood-derived cytokine-induced killer/natural killer cells.
Li Y; Schmidt-Wolf IG; Wu YF; Huang SL; Wei J; Fang J; Huang K; Zhou DH
Anticancer Res; 2010 Sep; 30(9):3493-9. PubMed ID: 20944128
[TBL] [Abstract][Full Text] [Related]
17. Autologous Cytokine-Induced Killer Cell Immunotherapy for Patients with High-Risk Diffuse Large B Cell Lymphoma After the First Complete Remission.
Zhou M; Wang J; Li CP; Xu JY; Chen B
Onco Targets Ther; 2020; 13():5879-5885. PubMed ID: 32606798
[TBL] [Abstract][Full Text] [Related]
18. Biological Character of RetroNectin Activated Cytokine-Induced Killer Cells.
Han L; Shang YM; Song YP; Gao QL
J Immunol Res; 2016; 2016():5706814. PubMed ID: 27433478
[TBL] [Abstract][Full Text] [Related]
19. [Clinical study of autologous cytokine induced killer cells combined with chemotherapy for elderly patients with acute myeloid leukemia].
Yang Y; Yang B; Cai LL; Ran HH; Yu RL; Chi XH; Zhu HL; Li SX; Liu Y; Wang Y; Han WD; Yao SQ; Lu XC
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2014 Feb; 22(1):58-63. PubMed ID: 24598652
[TBL] [Abstract][Full Text] [Related]
20. A novel population of expanded human CD3+CD56+ cells derived from T cells with potent in vivo antitumor activity in mice with severe combined immunodeficiency.
Lu PH; Negrin RS
J Immunol; 1994 Aug; 153(4):1687-96. PubMed ID: 7519209
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
